Russia looks for traces of extra-terrestrial life forms on ISS surfaceScience & Space May 26, 13:04
Press review: NATO's anti-terror Trump card and US' Afghan civilian body countPress Review May 26, 13:00
Russia urges NATO to stop attempts of building ties in confrontation spiritRussian Politics & Diplomacy May 26, 12:01
Russia to sell over 360 cutting-edge helicopters by 2030Military & Defense May 26, 11:37
Trump’s limo too big to fit through Royal Palace gates in BrusselsWorld May 26, 11:18
Russian ambassador says Paris remains important partner for MoscowRussian Politics & Diplomacy May 26, 10:20
Forest fires in Siberia swell four times to cover 30,000 hectaresWorld May 26, 9:45
Seoul pins hopes on Moscow in resolving tensions on Korean PeninsulaWorld May 26, 9:14
Space technologies offer glimpse at Tsar Ivan the Terrible’s rare portraitSociety & Culture May 26, 8:05
MOSCOW, December 15. /TASS/. The clinical trials for Russia’s Ebola vaccine were successful, Anna Popova, head of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, told reporters on Thursday.
"The Ebola vaccine has passed clinical trials successfully, documents for its registration are being prepared. It showed very good results," she said.
The first phase of clinical trials for the Ebola vaccine developed by the Novosibirsk-based Vector State Research Center of Virology and Biotechnology ended in June 2016, while the second began on September 8 and ended on December 8.
According to the World Health Organization (WHO), the Ebola outbreak recorded in West Africa in 2014-2015 took the lives of more than 11,000, while over 28,000 have been infected with the disease. The bulk of fatal cases occurred in Liberia, Sierra Leone and Guinea. According to the WHO, that was the largest Ebola outbreak in history.
Founded in 1974, the Vector Research Center of Virology and Biotechnology is one of the largest of its kind in the world. Initially, it studied the pathogens of such deadly diseases as anthrax and tularemia in order to develop biological weapons on their basis. Currently, Vector is developing means to diagnose and treat infectious diseases. The center’s experts are working on vaccines against swine flu, HIV and Ebola.